logo 胸外文献每日监控
2026年8月13日星期四
← 返回 全部文献

对比增强CT影像组学在实性成分占比≥25%的肺腺癌中识别高级别模式及预后分层

Contrast-enhanced CT Radiomics for High-Grade Pattern Identification and Prognostic Stratification in Lung Adenocarcinoma with Consolidation-to-Tumor Ratio of 25% or More.

期刊
Radiology
PMID
42578790
原文
PubMed ↗
发布日期

作者

  • Jiahui E — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Liuqing Kang — Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Zhengzhou, China.
  • Fan Liu — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Dianzhe Wang — Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Jingyi Yang — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Xiaoyan Lu — Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Zhengzhou, China.
  • Yong Huang — Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Jing Li — Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Zhengzhou, China.
  • Yicai Zhang — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Qiliang Wang — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Xiaoting Cai — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Bole Gao — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Zhuo Ning — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Ying Liu — Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.

作者单位

  • Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer/Tianjin's Clinical Research Center for Cancer/Key Laboratory of Cancer Prevention and Therapy, Huanhuxi Rd, Tiyuanbei, Hexi District, Tianjin 300060, China.
  • Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Zhengzhou, China.
  • Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

摘要

中文

背景 影像组学可能在本前识别肺腺癌(ADC)中的高级别模式(HGPs)并辅助临床决策。目的 开发并评估基于术前对比增强CT图像的机器学习模型以预测HGPs,并探索该模型的预后价值。材料与方法 回顾性纳入2017年1月至2025年5月在三家中心接受手术的临床I期浸润性ADC患者。基于HGP比例进行二元(低风险:HGP<20%;高风险:HGP≥20%)和三元(HGP0:HGP=0;HGP1:0<HGP<20%;HGP2:HGP≥20%)分类分析。使用多变量逻辑回归分析确定HGPs的独立预测因子。构建了基于XGBoost分类器的影像组学模型和组合模型(影像组学预测概率加临床变量加CT语义特征),并评估其判别能力、校准能力和临床实用性。进行Kaplan-Meier和Cox回归分析以确定总生存期(OS)和无复发生存期(RFS)的预后因素。结果 共1,181名患者(中位年龄61岁[IQR, 54-66岁];694名女性)被分配到训练集(n=667)、内部测试集(n=279)和外部测试集(n=235)。组合模型在二元分类(训练集:受试者工作特征曲线下面积[AUC] 0.87 [95% CI: 0.84, 0.90];内部测试:AUC 0.80 [95% CI: 0.74, 0.85];外部测试:AUC 0.84 [95% CI: 0.78, 0.90])和三元分类(训练集:微平均AUC 0.80 [95% CI: 0.78, 0.82];内部测试:微平均AUC 0.74 [95% CI: 0.70, 0.77];外部测试:微平均AUC 0.72 [95% CI: 0.68, 0.76])中均达到最佳判别能力。模型预测的高风险组是OS(二元:风险比[HR]=1.98, P=.04;三元:HR=2.93, P=.03)和RFS(二元:HR=3.33, P<.001;三元:HR=5.10, P<.001)的独立预后因素,并在亚组分析中一致确认。结论 结合临床变量、CT语义特征和影像组学预测概率的组合模型有效预测了肺ADC中的高级别模式,并显示出强大的预后风险分层潜力。© RSNA, 2026 本文提供补充材料。另见本期Arita和Kocak的社论。

English

Background Radiomics may preoperatively identify high-grade patterns (HGPs) in lung adenocarcinoma (ADC) and assist in clinical decision-making. Purpose To develop and evaluate a machine learning model based on preoperative contrast-enhanced CT images to predict HGPs and explore the model's prognostic value. Materials and Methods Patients with clinical stage I invasive ADC who underwent surgery (January 2017 to May 2025) were retrospectively enrolled from three centers. Binary (low risk: HGPs < 20%; high risk: HGPs ≥ 20%) and ternary (HGP0: HGPs = 0; HGP1: 0 < HGPs < 20%; HGP2: HGPs ≥ 20%) classification analyses were performed based on the proportion of HGPs. Multivariable logistic regression analysis was used to determine independent predictors of HGPs. XGBoost classifier-based radiomic models and combined models (radiomics-predicted probabilities plus clinical variables plus CT semantic features) were constructed and evaluated for discriminability, calibration ability, and clinical utility. Kaplan-Meier and Cox regression analyses were conducted to identify prognostic factors for overall survival (OS) and recurrence-free survival (RFS). Results A total of 1181 patients (median age, 61 years [IQR, 54-66 years]; 694 female) were allocated to the training (n = 667), internal test (n = 279), and external test (n = 235) sets. The combined model achieved the best discrimination in both binary (training: area under the receiver operating characteristic curve [AUC], 0.87 [95% CI: 0.84, 0.90]; internal test: AUC, 0.80 [95% CI: 0.74, 0.85]; external test: AUC, 0.84 [95% CI: 0.78, 0.90]) and ternary (training: microaverage AUC, 0.80 [95% CI: 0.78, 0.82]; internal test: microaverage AUC, 0.74 [95% CI: 0.70, 0.77]; external test: microaverage AUC, 0.72 [95% CI: 0.68, 0.76]) classification analyses. Model-predicted high-risk group was an independent prognostic factor for both OS (binary: hazard ratio [HR] = 1.98, P =.04; ternary: HR = 2.93, P =.03) and RFS (binary: HR = 3.33, P < .001; ternary: HR = 5.10, P < .001) and was consistently confirmed across subgroup analyses. Conclusion The combined model, integrating clinical variables, CT semantic features, and radiomics-predicted probabilities, effectively predicted high-grade patterns in lung ADC and showed strong potential for prognostic risk stratification. © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Arita and Kocak in this issue.

分类与指标

研究类型
AI/ML
病种
肺癌
JCR 分区
Q1
影响因子
17.6
新锐分区
1区